undamentalytics Newsletter
Sign in

Ispecimen Inc. balance sheet

At the end of fiscal 2025, Ispecimen Inc. had total assets of $9.5m, total liabilities of $6.4m and shareholders' equity of $3.1m. It held $6.9m in cash against $0 of debt: net cash of $6.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents128152274
Receivables2321100
Inventory————0——
Total current assets333208474
Total assets63625169107
Accounts payable2124455
Deferred revenue (current)1100000
Total current liabilities22346665
Long-term debt—3—————
Total debt1440000
Total liabilities22646666
Shareholders' equity−27302010332
Non-controlling interests and other (assets − liabilities − equity)11——————
Net debt (negative = net cash)−0−24−11−2−2−7−4
Shares outstanding—————4m2m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ISPC vs YDESISPC vs QSIACON vs ISPC

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Ispecimen Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ispecimen Inc.